𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Restrictive Eligibility Limits Access to Newer Therapies in Non–Small-Cell Lung Cancer: The Implications of Eastern Cooperative Oncology Group 4599

✍ Scribed by Robert A. Somer; Eric Sherman; Corey J. Langer

Book ID
119935569
Publisher
CIG Media Group, LP.
Year
2008
Tongue
English
Weight
111 KB
Volume
9
Category
Article
ISSN
1525-7304

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of N-methylformamide, spi
Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern cooperative oncology group study
✍ Ettinger, David S. ;Finkelstein, Dianne M. ;Donehower, Ross C. ;Chang, Alex Y. C 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

One hundred forty-four patients with non-small cell lung cancer, the majority (72%) of whom had received previous chemotherapy, were evaluable in this randomized phase II study of N-methylformamide (N-MF), spirogermanium, and 4-demethoxydaunorubicin. There were two partial responses, one each with s